Inclusion Criteria:

- Patients with epithelial carcinoma arising in the ovary, fallopian tube or
peritoneum, stages I-IV. These patients must have received initial surgery and
chemotherapy with at least one platinum based chemotherapy regimen.

- Patients must have relapsed and now have completed chemotherapy for recurrent disease
within the last 6 weeks.

- Eligible patients may have asymptomatic residual measurable disease on CT scan,
and/or may have an elevated CA-125, or may be in complete clinical remission.

- Patients must have adequate hematologic, renal and hepatic functions.

Exclusion Criteria:

- Patients with any other active malignancy concomitantly

- Patients within 3 weeks of prior cytotoxic or investigational chemotherapy

- Patients within 4 weeks of prior radiotherapy

- Patients within 6 weeks of prior immunotherapy

- Patients who have received any prior anti-cancer vaccine